Revenue | $100 - $500 million See Exact Annual Revenue |
---|---|
Employees | 10 - 100Exact Company Size |
Primary Industry | 3254 Pharmaceutical & Medicine Manufacturing |
Address | 6550 Dumbarton Cir Ste A Fremont, CA 94555 |
Alexza Pharmaceuticals | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
---|---|---|---|
2023 | $100 - $500 million Details in Premium Report | ||
2022 | |||
2021 | |||
2020 | |||
2019 |
1-Year Growth Rate: 3-Year Growth Rate (CAGR): |
Alexza Pharmaceuticals P&L | $ Millions |
---|---|
Revenue (Sales) | |
Cost of Goods Sold | |
Gross Profit | |
Operating Expenses | |
Advertising | |
Salaries and wages | |
Other Operating Expenses | |
Total Operating Expenses | |
Operating Income | |
EBITDA | |
EBIT (Earnings Before Interest and Taxes) | |
Net Profit | |
Trademark | Date |
---|---|
OBT Pharmaceutical preparations for the diagnosis and treatment of psychiatric disorders, neurological disorders, and gastrointestinal disorders, and analgesics; pharmaceutical delivery devices in the nature of inhalers filled with drugs and diagnostic preparations for the detection and treatment of psychiatric disorders, neurological disorders, gastrointestinal disorders, and pain | 06/03/2019 |
ONE BREATH TECHNOLOGY Pharmaceutical preparations for the diagnosis and treatment of psychiatric disorders, neurological disorders, and gastrointestinal disorders, and analgesics; pharmaceutical delivery devices in the nature of inhalers filled with drugs and diagnostic preparations for the detection and treatment of psychiatric disorders, neurological disorders, gastrointestinal disorders, and pain | 09/01/2017 |
ENGAGE THERAPEUTICS Pharmaceutical preparations for the diagnosis and treatment of psychiatric disorders, neurological disorders, gastrointestinal disorders, and central nervous system disorders; pharmaceutical delivery devices in the nature of inhalers filled with drugs and diagnostic preparations for the detection and treatment of psychiatric disorders, neurological disorders, gastrointestinal disorders, and central nervous system disorders | 04/06/2015 |
Company | Headquarters | Revenue ($ MM) |
---|---|---|
PFIZER | New York, NY | 100 |
ABBOTT LABORATORIES | Abbott Park, IL | 78 |
BRISTOL-MYERS SQUIBB | Lawrenceville, NJ | 78 |
ELI LILLY | Indianapolis, IN | 59 |
MERCK SHARP & DOHME | Rahway, NJ | 56 |
CSL BEHRING | King Of Prussia, PA | 55 |
CSLB HOLDINGS | King Of Prussia, PA | 54 |
MERCK | Rahway, NJ | 53 |
ALLERGAN | North Chicago, IL | 53 |
Company | Headquarters | Revenue ($ MM) |
---|---|---|
IMPAX LABORATORIES | Hayward, CA | 100 |
SIGHTGLASS MGMT | Alameda, CA | 84 |
ASTEX PHARMACEUTICALS | Pleasanton, CA | 25 |
INTUITY MEDICAL | Fremont, CA | 25 |
ALEXZA PHARMACEUTICALS | Fremont, CA | 19 |
VECTOR LABORATORIES | Newark, CA | 15 |
Company | Revenue ($ MM) |
---|---|
|